Skip to main content
. 2022 Mar 5;10(5):e15209. doi: 10.14814/phy2.15209

TABLE 2.

Medication use at study initiation

ARNi (N = 10) Control (N = 10)
β‐blocker 10/10 10/10
ACEi/ARB 10/10 10/10
Statin/Lipid lowering medications 10/10 10/10
Aldosterone antagonist 1/10 0/10
Hydralazine/Nitrates 1/10 1/10
Loop diuretics 4/10 4/10
Antiplatelet 10/10 10/10
Anticoagulant 5/10 2/10

Values are n.

Abbreviations: ACEi, angiotensin‐converting‐enzyme inhibitors; ARB, angiotensin receptor blockers.